S&P 500   4,594.63
DOW   36,245.50
QQQ   389.94
15 best consumer discretionary stocks for the rest of 2023
All the trading advice you’ve ever received boils down to this (Ad)
Energy traders: A rebound is coming
Kroger shares are begging to be bought 
All the trading advice you’ve ever received boils down to this (Ad)
Behind the tech boom: Big price leaders selectively laying off
Dallas Mavericks purchase turns LVS stock into a cheaper bet
All the trading advice you’ve ever received boils down to this (Ad)
These biotechs targeting multiple neurodegenerative diseases
Earnings propel Crowdstrike, cybersecurity sector, to new highs
S&P 500   4,594.63
DOW   36,245.50
QQQ   389.94
15 best consumer discretionary stocks for the rest of 2023
All the trading advice you’ve ever received boils down to this (Ad)
Energy traders: A rebound is coming
Kroger shares are begging to be bought 
All the trading advice you’ve ever received boils down to this (Ad)
Behind the tech boom: Big price leaders selectively laying off
Dallas Mavericks purchase turns LVS stock into a cheaper bet
All the trading advice you’ve ever received boils down to this (Ad)
These biotechs targeting multiple neurodegenerative diseases
Earnings propel Crowdstrike, cybersecurity sector, to new highs
S&P 500   4,594.63
DOW   36,245.50
QQQ   389.94
15 best consumer discretionary stocks for the rest of 2023
All the trading advice you’ve ever received boils down to this (Ad)
Energy traders: A rebound is coming
Kroger shares are begging to be bought 
All the trading advice you’ve ever received boils down to this (Ad)
Behind the tech boom: Big price leaders selectively laying off
Dallas Mavericks purchase turns LVS stock into a cheaper bet
All the trading advice you’ve ever received boils down to this (Ad)
These biotechs targeting multiple neurodegenerative diseases
Earnings propel Crowdstrike, cybersecurity sector, to new highs
S&P 500   4,594.63
DOW   36,245.50
QQQ   389.94
15 best consumer discretionary stocks for the rest of 2023
All the trading advice you’ve ever received boils down to this (Ad)
Energy traders: A rebound is coming
Kroger shares are begging to be bought 
All the trading advice you’ve ever received boils down to this (Ad)
Behind the tech boom: Big price leaders selectively laying off
Dallas Mavericks purchase turns LVS stock into a cheaper bet
All the trading advice you’ve ever received boils down to this (Ad)
These biotechs targeting multiple neurodegenerative diseases
Earnings propel Crowdstrike, cybersecurity sector, to new highs

Oragenics Stock Price, News & Analysis (NYSEAMERICAN:OGEN)

$3.46
-0.12 (-3.35%)
(As of 12/1/2023 ET)
Compare
Today's Range
$3.46
$3.80
50-Day Range
$2.94
$4.18
52-Week Range
$2.60
$12.33
Volume
7,923 shs
Average Volume
3,952 shs
Market Capitalization
$8.89 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A

Oragenics MarketRank™ Stock Analysis

Analyst Rating
N/A
Upside/​Downside
N/A
Short Interest
Healthy
2.11% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
0.00mentions of Oragenics in the last 14 days
Based on 3 Articles This Week
Insider Trading
Selling Shares
$12,495 Sold Last Quarter
Proj. Earnings Growth
N/A

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

1.44 out of 5 stars


OGEN stock logo

About Oragenics Stock (NYSEAMERICAN:OGEN)

Oragenics, Inc., a development-stage company, engages in the research and development of antibiotics for infectious diseases in the United States. The company engages in the development and commercialization of NT-CoV2-1, an intranasal vaccine candidate that provides immunity from the novel severe acute respiratory syndrome coronavirus. The company's product candidates also comprise LPT3-04, a weight loss candidate; and SMaRT Replacement Therapy, a topical treatment to prevent dental carries. It has a license agreement with Noachis Terra Inc. for licensing of certain specified patent rights and biological materials relating to the use of pre-fusion coronavirus spike proteins; and a collaboration agreement ILH Holdings, Inc. for the development and commercialization of MU1140 and related homologs. The company was formerly known as Oragen, Inc. Oragenics, Inc. was incorporated in 1996 and is headquartered in Tampa, Florida.

OGEN Stock Price History

OGEN Stock News Headlines

StockNews.com Initiates Coverage on Oragenics (NYSEAMERICAN:OGEN)
StockNews.com Begins Coverage on Oragenics (NYSEAMERICAN:OGEN)
Trading Experts Call It “The Perfect Tesla Trade”
Thanks to a new discovery linked to shares of Tesla, regular folks can now target gains of 100% or more in six days or less. New research shows it’s happened 23 different times this year. The next trade is scheduled for this Thursday.
Oragenics, Inc. (UAV.F)
Oragenics Issues Update to Shareholders
Trading Experts Call It “The Perfect Tesla Trade”
Thanks to a new discovery linked to shares of Tesla, regular folks can now target gains of 100% or more in six days or less. New research shows it’s happened 23 different times this year. The next trade is scheduled for this Thursday.
Oragenics, Inc. Announces Private Placement
Oragenics, Inc. Regains Compliance with NYSE American
Oragenics, Inc. Receives NYSE American Notice
Oragenics, Inc. Announces New Chair
Oragenics Inc OGEN Stock Quote
See More Headlines
Receive OGEN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Oragenics and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
11/09/2023
Today
12/01/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Pharmaceutical preparations
Sub-Industry
N/A
Sector
Medical
Current Symbol
NYSEAMERICAN:OGEN
Employees
6
Year Founded
N/A

Profitability

Net Income
$-14,290,000.00
Pretax Margin
-26,700.00%

Debt

Sales & Book Value

Annual Sales
$130,000.00
Book Value
$1.91 per share

Miscellaneous

Free Float
1,937,000
Market Cap
$8.89 million
Optionable
Not Optionable
Beta
0.53
12 Stocks Corporate Insiders are Abandoning Cover

If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know?

Get This Free Report














OGEN Stock Analysis - Frequently Asked Questions

How have OGEN shares performed in 2023?

Oragenics' stock was trading at $0.1051 at the beginning of 2023. Since then, OGEN stock has increased by 3,192.1% and is now trading at $3.46.
View the best growth stocks for 2023 here
.

Are investors shorting Oragenics?

Oragenics saw a decrease in short interest in October. As of October 31st, there was short interest totaling 52,400 shares, a decrease of 25.9% from the October 15th total of 70,700 shares. Based on an average trading volume of 17,400 shares, the days-to-cover ratio is currently 3.0 days. Approximately 2.5% of the shares of the company are short sold.
View Oragenics' Short Interest
.

How were Oragenics' earnings last quarter?

Oragenics, Inc. (NYSEAMERICAN:OGEN) posted its quarterly earnings data on Thursday, November, 9th. The biotechnology company reported ($0.85) EPS for the quarter. The biotechnology company earned $0.01 million during the quarter.

When did Oragenics' stock split?

Oragenics shares reverse split before market open on Monday, January 23rd 2023. The 1-60 reverse split was announced on Monday, January 23rd 2023. The number of shares owned by shareholders was adjusted after the closing bell on Monday, January 23rd 2023. An investor that had 100 shares of stock prior to the reverse split would have 2 shares after the split.

What other stocks do shareholders of Oragenics own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Oragenics investors own include Imunon (CLSN), Jaguar Health (JAGX), Biocept (BIOC), OPKO Health (OPK), Sorrento Therapeutics (SRNE), Amarin (AMRN), Heat Biologics (HTBX), Idera Pharmaceuticals (IDRA) and Achieve Life Sciences (ACHV).

How do I buy shares of Oragenics?

Shares of OGEN stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

This page (NYSEAMERICAN:OGEN) was last updated on 12/2/2023 by MarketBeat.com Staff

My Account -